FEB 15, 2018 4:29 AM PST

A New Electronic Cigarette Faces Opposition

Cigarettes are bad for you. The science is clear on that, and there have been warnings about the dangers of smoking on packs of cigarettes for decades. From heart disease to high blood pressure and cancer, the list of illnesses and health problems that arise from tobacco use is long.

Tobacco company Phillip Morris wants to sell a product that it claims is a "reduced risk" e-cigarette called iQOS, but a panel of advisers to the FDA has ruled that the language in some of the marketing of the product is misleading.

iQOS is similar to a vape pen. Sticks of tobacco, made by Phillip Morris and branded as Marlboros are heated up by the device, but the plant isn't burned. The company alleges that the "heat not burn" action of the e-cig means that users are exposed to less tar and chemicals, and the device is, therefore, safer than traditional cigarettes. The FDA has only recently been given authority to regulate e-cigarette devices.

The iQOS device is known as a "Modified Risk Tobacco Product" (MRTP), and marketing language and claims about safety must meet FDA standards. The advisory panel to the FDA said that while they would allow the company to say that the heating process does cause less exposure to chemicals, they found that there was no evidence to prove that this correlates to a lower risk of disease in users.

The device is already available in about 30 countries. Most e-cigarettes and vapor pens do not include actual tobacco, but fruit- flavored juices, some of which contain nicotine. Many smokers who are trying to quit use them to break the habit, but some say that the flavor they like from tobacco is missing from e-cigs. The FDA advisory panel cited irregularities in some of the clinical trials that Phillip Morris conducted as well as a lack of evidence that the product is less dangerous than regular cigarettes. To date, no MRTP products have been approved by the FDA. Phillip Morris was counting on being first to the market with their device, but it doesn't look as if they will succeed.

In a letter to the FDA's commissioner Scott Gottlieb, ten United States senators urged the agency to "avoid rushing through new products, such as IQOS, to fit within this evolving FDA policy, without requiring strong evidence that any such product will reduce the risk of disease, result in a large number of smokers quitting, and not increase youth tobacco use." While the product has been available in other countries since 2014, the US market remains elusive. The advisory panel's recommendations are not binding, and the FDA will issue its decision on the product in a few weeks. While smoking has fallen to record lows in the United States, with only 15% of Americans reporting that they smoke on a regular basis, it's still the leading cause of preventable deaths and illnesses.

The video below has an in-depth look at the product and the research behind it. For now, it remains to be seen if these new devices will become available.

Sources: Reuters, Associated Press/Time.com, FDA

About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
OCT 01, 2020
Cell & Molecular Biology
Signaling Waves Help Guide Cells to Heal Wounds
OCT 01, 2020
Signaling Waves Help Guide Cells to Heal Wounds
During development and throughout our lives, cells have to 'know' where to go to form the right structures and properly ...
OCT 03, 2020
Genetics & Genomics
Genetic Changes Can Influence Cocaine Addiction
OCT 03, 2020
Genetic Changes Can Influence Cocaine Addiction
There is no treatment for cocaine addiction, which affects millions of people around the world and has a high relapse ra ...
OCT 07, 2020
Cancer
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
OCT 07, 2020
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
Over the years, cancer researchers have struggled not just with drug and diagnostic design, but with drug delivery. The ...
OCT 05, 2020
Cell & Molecular Biology
Gaining Insight Into the Connection Between Depression and Stress
OCT 05, 2020
Gaining Insight Into the Connection Between Depression and Stress
Depression is a common mental illness, and stress is known to be an environmental influence that can increase the risk o ...
OCT 11, 2020
Plants & Animals
Fungal Disease Affecting Snakes Is More Widespread Than Thought
OCT 11, 2020
Fungal Disease Affecting Snakes Is More Widespread Than Thought
A team of researchers and personnel on military bases have reported in a project in which they looked for an emerging fu ...
OCT 18, 2020
Cardiology
Many Heart Disease Deaths Are Preventable With Diet Improvements
OCT 18, 2020
Many Heart Disease Deaths Are Preventable With Diet Improvements
New research has suggested that over two-thirds of heart disease cases around the world are preventable with improvement ...
Loading Comments...